blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1713820

EP1713820 - SELECTIVE ESTROGEN RECEPTOR MODULATORS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  25.11.2011
Database last updated on 13.09.2024
Most recent event   Tooltip25.11.2011Application deemed to be withdrawnpublished on 28.12.2011  [2011/52]
Applicant(s)For all designated states
ELI LILLY AND COMPANY
Lilly Corporate Center
Indianapolis, IN 46285 / US
[N/P]
Former [2006/43]For all designated states
ELI LILLY AND COMPANY
Lilly Corporate Center
Indianapolis IN 46285 / US
Inventor(s)01 / DODGE, Jeffrey, Alan
7110 Lantern Road
Indianapolis, Indiana 46256 / US
02 / HOPKINS, Randall, Bruce
956 North Audubon Road
Indianapolis, Indiana 46219 / US
03 / WALLACE, Owen, Brendan
4341 Chase Circle
Zionsville, Indiana 46077 / US
 [2006/43]
Representative(s)Burnside, Ivan John
Eli Lilly and Company Limited
8 Arlington Square West Downshire Way
Bracknell, Berkshire RG12 1PU / GB
[N/P]
Former [2006/43]Burnside, Ivan John
Eli Lilly and Company Limited European Patent Operations Lilly Research Centre Erl Wood Manor, Sunnighill Road
Windlesham, Surrey GU20 6PH / GB
Application number, filing date05704873.818.01.2005
[2006/43]
WO2005US00019
Priority number, dateUS20040538302P22.01.2004         Original published format: US 538302 P
[2006/43]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2005073244
Date:11.08.2005
Language:EN
[2005/32]
Type: A1 Application with search report 
No.:EP1713820
Date:25.10.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 11.08.2005 takes the place of the publication of the European patent application.
[2006/43]
Search report(s)International search report - published on:EP11.08.2005
ClassificationIPC:C07J73/00, A61K31/56, A61P5/32
[2006/43]
CPC:
C07J73/003 (EP); A61P5/32 (EP); C07J73/006 (EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/43]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
LVNot yet paid
MKNot yet paid
YUNot yet paid
TitleGerman:SELEKTIVE ÖSTROGEN-REZEPTOR-MODULATOREN[2006/43]
English:SELECTIVE ESTROGEN RECEPTOR MODULATORS[2006/43]
French:MODULATEURS SELECTIFS DU RECEPTEUR DES OESTROGENES[2006/43]
Entry into regional phase22.08.2006National basic fee paid 
22.08.2006Designation fee(s) paid 
22.08.2006Examination fee paid 
Examination procedure22.08.2006Amendment by applicant (claims and/or description)
22.08.2006Examination requested  [2006/43]
21.02.2011Despatch of a communication from the examining division (Time limit: M04)
05.07.2011Application deemed to be withdrawn, date of legal effect  [2011/52]
09.08.2011Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2011/52]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  21.02.2011
Fees paidRenewal fee
31.01.2007Renewal fee patent year 03
31.01.2008Renewal fee patent year 04
02.02.2009Renewal fee patent year 05
01.02.2010Renewal fee patent year 06
31.01.2011Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[Y]EP0761669  (LILLY CO ELI [US]) [Y] 1-21 * claim 1 * * page 43; example 11b *;
 [Y]WO03053977  (ORTHO MCNEIL PHARM INC [US]) [Y] 1-21 * claim 1 *
 [Y]  - GRESE T A ET AL, "Synthesis and pharmacology of conformationally restricted raloxifene analogues: highly potent selective estrogen receptor modulators", JOURNAL OF ORGANIC CHEMISTRY, AMERICAN CHEMICAL SOCIETY. EASTON, US, (1998), vol. 41, no. 8, ISSN 0022-3263, pages 1272 - 1283, XP002208889 [Y] 1-21 * page 1274; compound 4 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.